Treatment of liposclerosis of the leg by fibrinolytic enhancement: a preliminary report.
- 13 August 1977
- Vol. 2 (6084), 434-435
- https://doi.org/10.1136/bmj.2.6084.434
Abstract
Fourteen patients with longstanding lipodermatosclerosis of their lower legs, secondary to venous disease in 11, were treated for three months with stanozolol, a drug that enhances fibrinolytic activity. No other treatment was given and no change made in existing treatment. All the patients improved. Two were cured in three months, three were able to stop treatment in the next three to 11 months, and the other nine continued to improve. Fibrinolytic enhancement, with stanozolol, seems to be a worthwhile addition to the treatment of venous liposclerosis and deserves further study.Keywords
This publication has 6 references indexed in Scilit:
- Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.BMJ, 1977
- Blood and vein-wall fibrinolytic activity in health and vascular disease.BMJ, 1977
- Proceedings: Extravascular fibrin deposition in response to venous hypertension-the cause of venous ulcers.1976
- Fibrinolytic Enhancement by Stanozolol: A Double Blind TrialBritish Journal of Haematology, 1972
- EVIDENCE OF A DIURNAL FIBRINOLYTIC RHYTHM - WITH A SIMPLE METHOD OF MEASURING NATURAL FIBRINOLYSIS1957
- The fibrin plate method for estimating fibrinolytic activityArchives of Biochemistry and Biophysics, 1952